3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Venous Thromboembolism
5
Neoplasms
2
Multiple Myeloma
2
Urologic Neoplasms
1
Urogenital Neoplasms
1
Pulmonary Embolism
1
Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
1
Lymphoma
1
Leukemia
1
Hematologic Neoplasms
1
Embolism
1
Interventions
epigallocatechin gallate
2
Ascorbic Acid
2
semaglutide
1
microcrystalline cellulose
1
dapagliflozin
1
cytisine
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
XENP 1595
1
Vitamin D
1
Topiramate
1
Tirzepatide
1
Spirometry
1
Selenium
1
Saline Solution
1
Resistance Training
1
Reperfusion
1
Qsymia
1
Probiotics
1
Platelet Count
1
Plastic Surgery Procedures
1
Phentermine
1
Naltrexone
1
Losartan
1
Liraglutide
1
Ischemic Preconditioning
1
Hematologic Tests
1
Glucagon-Like Peptide-1 Receptor
1
Endurance Training
1
Diethylpropion
1
Diet Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Inflammation
×
Rivaroxaban
×
1 year
×
Clear all
No trials found.